47 results found

Haixia Wang, Liming Zhu, Yongting Yang, Binru Fang, Shunjie Jiang, Jin Wu

Background Adverse Event Reporting Systems (AERS) are essential tools for improving patient safety, yet under-reporting by medical staff remains a persistent challenge. Existing studies mainly adopt v...

BMC Health Services Research 2026-04-24 rs-9142870
Adverse event reporting Reporting intention Latent profile analysis

Ulka Vaishampayan, Jeremy (M. G.) Taylor, Deepak Kilari, Tanya Dorff, Alexandra Sokolava, Yaxuan Huang, Phillip Palmbos, Jacqueline Brown, Irene Tsung, Megan Caram, Sarah Yentz, Bassel Nazha, Zachery Reichert, Joshi Alumkal

Background: Effective therapies remain a currently unmet need for neuroendocrine prostate cancer (NEPC). Preclinical synergy in small cell cancer, and clinical tolerability led to the conduct of a mul...

Nature Portfolio 2026-04-23 rs-9471666
immune checkpoint therapy anti-vascular therapy small cell prostate cancer

Arman Ghavidel, Pilar Pazos, Hyoshin J. Park, John Seems

Prostate cancer risk prediction remains challenged by the inability to reliably distinguish indolent from aggressive disease, leading to overtreatment or undertreatment. Conventional approaches based ...

Research Square 2026-04-23 rs-9490581
Prostate cancer Risk stratification Longitudinal PSA/DRE Deep learning Outcome-guided clustering

Sara Pires, Lapo Mughini-Gras, Sandra Hoffmann, Kunihiro Kubota, Shannon Majowicz, Martyn Kirk, Lucy Robertson, Paul Torgerson, Lea Jakobsen, Antonio Agudo, Li Bai, Tety Rachmawati, Yuki Minato, Charlee Roberts, Arie Havelaar, Brecht Devleesschauwer, Elisa Benincà, Robin Lake, Tine Hald, Roger Cooke, Willy Aspinall, Gabriela Nane

Identifying the sources of foodborne diseases is crucial for guiding national food safety strategies and supporting policies that promote safe and sustainable diets. We present global estimates of the...

Research Square 2026-04-23 rs-9449162

YiJian Lei, Yan Pu, Yuqin Chen, Tian Hu, Shanshan Li, Mengyu Zhang, Hu Zhao, Zhiru Tang

This study investigated regional variations in hospitalization expenses for lung malignant tumor patients within tertiary hospitals. Using H City as the reference point and comparing it with B, M, and...

BMC Health Services Research 2026-04-23 rs-9142686
multiple linear regression path analysis hospitalization expenses malignant tumor payment reform

Sonam Kundral, Puneet Kumar, Vikram Sharma, Sangh Partap

This in-depth investigation employs network pharmacology and molecular docking methodologies to analyse various phytocompounds extracted from the hamamelis plant, with a specific focus on uncovering p...

In Silico Pharmacology 2026-04-23 rs-9341649
Hamamelis Imppaat PubChem EGFR Cianidanol Lung cancer

Mingwei Liang, Xinxin Zhang, Wenli Wu, Ruijie Yu, Zhiruo Liao, Qianqian Cao, Xiyue Su, Jia lu, Jihua Wang

Background Incorporating immunotherapy effectively remains a priority in therapeutic research of ovarian cancer, making it essential to conduct and report randomized, controlled trials (RCTs) with hig...

BMC Cancer 2026-04-23 rs-9020902
CONSORT statement ovarian cancer immunotherapy reporting quality randomized controlled trial

Wei Chen, Wenhua Xie, Jing Jin, Yifang Cao, Li Guo, Linfeng Lu, Yanqin Gu, Siyu Lei, Wei Zhu, Yi He

Background Transurethral resection of bladder tumor (TURBT) is the standard treatment for non-muscle-invasive bladder cancer (NMIBC), but the high rates of residual tumor and recurrence remain major c...

World Journal of Surgical Oncology 2026-04-23 rs-9223803
UroCAD bladder cancer TURBT chromosomal instability recurrence

Prem Raj Shrestha, Kalawati Shrestha, Prajwal Pudasaini, Huawei Weng, Tongyu Lin

Background Rituximab based chemotherapy regimens, particularly R-CHOP, are highly effective for the treatment of B-cell lymphoma (BCL) but are frequently complicated by pulmonary adverse effects (PAEs...

BMC Cancer 2026-04-23 rs-9145705
rituximab pulmonary adverse effects thymosin α1 intravenous immunoglobulin event-free survival

Faraz Saif, Fakhra Nain Qureshi, Azaz Ahmad, Fakeeda Durrani, Noor Ul Ain Azam, Imad Ullah, Zia Ud Din Ahmed, Asif Riaz Khan

Purpose The neutrophil-to-lymphocyte ratio (NLR) is an emerging biomarker for predicting febrile neutropenia (FN) in cancer patients. This study aimed to evaluate the association between pre-treatment...

Supportive Care in Cancer 2026-04-23 rs-9106686
Neutrophil-to-lymphocyte ratio (NLR) febrile neutropenia breast cancer ovarian cancer
Back to Top
Home
Browse
Submit
About
0.052843s